o	Subjects participating in another clinical trial 
o	Subjects who are pregnant or breastfeeding 
o	Subjects who are unwilling or unable to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examinations including follow up 
o	Subjects who are unable to swallow study drugs whole as a tablet/capsule 
o	Subjects who have had a prior invasive malignancy, excluding successfully treated basal cell or squamous cell carcinoma of the skin or in situ cervical cancer, within the past 5 years 
o	Subjects who have had a prior malignancy, excluding successfully treated basal cell or squamous cell carcinoma of the skin or in situ cervical cancer, within the past 5 years 
o	Subjects who have had a prior malignancy, excluding successfully treated basal cell or squamous cell carcinoma of the skin or in situ cervical cancer, within the past 5 years 
o	Subjects who have had a prior malignancy, excluding successfully treated basal cell or squ